26 Towards an HIV functional cure with CAR-T cells: elucidating mechanisms underlying the extremely high potency of bispecific anti-HIV CARs designed for optimal activity and minimal immunogenicity
M.H. Ghanem,
B. Dey,
S. Bolivar-Wagers,
D. Vargas-Inchaustegui,
V. Bundoc,
D.T. Danielson,
D. Elias,
A. Hajduczki,
E.A. Berger
Affiliations
M.H. Ghanem
Molecular Structure Section, Laboratory of Viral Diseases, NIAID, NIH, Bethesda, Maryland, USA
B. Dey
Molecular Structure Section, Laboratory of Viral Diseases, NIAID, NIH, Bethesda, Maryland, USA
S. Bolivar-Wagers
Molecular Structure Section, Laboratory of Viral Diseases, NIAID, NIH, Bethesda, Maryland, USA
D. Vargas-Inchaustegui
Molecular Structure Section, Laboratory of Viral Diseases, NIAID, NIH, Bethesda, Maryland, USA
V. Bundoc
Molecular Structure Section, Laboratory of Viral Diseases, NIAID, NIH, Bethesda, Maryland, USA
D.T. Danielson
Molecular Structure Section, Laboratory of Viral Diseases, NIAID, NIH, Bethesda, Maryland, USA
D. Elias
Molecular Structure Section, Laboratory of Viral Diseases, NIAID, NIH, Bethesda, Maryland, USA
A. Hajduczki
Molecular Structure Section, Laboratory of Viral Diseases, NIAID, NIH, Bethesda, Maryland, USA
E.A. Berger
Molecular Structure Section, Laboratory of Viral Diseases, NIAID, NIH, Bethesda, Maryland, USA
